TATUM leverages synthetic biology to build a category-defining platform based on engineered phages capable of multitasking immunotherapies to break cancer resistances. This first-in-class modality triggers full-blown antitumor immune responses providing unparalleled clearance efficacy.
“ Stay humble and know how to surround yourself well! ”
– Jean-François Millau
Here are the companies that are at the heart of each of our decisions and that we are proud to support.
Together, let’s build the world of tomorrow.